Literature DB >> 23945497

Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.

José M Muñoz-Félix1, José M López-Novoa1, Carlos Martínez-Salgado2.   

Abstract

Tubulointerstitial fibrosis is characterized by an accumulation of extracellular matrix in the renal interstitium, myofibroblast activation, cell infiltration, and tubular cell apoptosis, leading to chronic renal failure. Activin receptor-like kinase 1 (ALK1) is a transforming growth factor-β1 type I receptor with a pivotal role in endothelial proliferation and migration, but its role in the development of renal fibrosis is unknown. To assess this we used the unilateral ureteral obstruction model of tubulointerstitial fibrosis in ALK1 haploinsufficient (ALK1(+/-)) and wild-type mice. After 15 days, there was an increase in extracellular matrix protein expression in the obstructed kidneys from both ALK1(+/+) and ALK1(+/-) mice, but obstructed kidneys from ALK1(+/-) mice showed significantly higher expression of type I collagen than those from wild-type mice. Ureteral obstruction increased kidney myofibroblasts markers (α-smooth muscle actin and S100A4), without differences between mouse genotypes. ALK1 expression was increased after ureteral obstruction, and this increased expression was located in myofibroblasts. Moreover, cultured renal fibroblasts from ALK1(+/-) mice expressed more collagen type I and fibronectin than fibroblasts derived from wild-type mice. Thus, ALK1 modulates obstruction-induced renal fibrosis by increased extracellular matrix synthesis in myofibroblasts, but without differences in myofibroblast number.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23945497     DOI: 10.1038/ki.2013.292

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Authors:  Hiroki Kobayashi; Helen C Looker; Eiichiro Satake; Francesca D'Addio; Jonathan M Wilson; Pierre Jean Saulnier; Zaipul I Md Dom; Kristina O'Neil; Katsuhito Ihara; Bozena Krolewski; Hannah S Badger; Adriana Petrazzuolo; Domenico Corradi; Andrzej Galecki; Parker C Wilson; Behzad Najafian; Michael Mauer; Monika A Niewczas; Alessandro Doria; Benjamin D Humphreys; Kevin L Duffin; Paolo Fiorina; Robert G Nelson; Andrzej S Krolewski
Journal:  Sci Transl Med       Date:  2022-08-10       Impact factor: 19.319

2.  Endothelial Activin Receptor-Like Kinase 1 (ALK1) Regulates Myofibroblast Emergence and Peritubular Capillary Stability in the Early Stages of Kidney Fibrosis.

Authors:  Carlos Martínez-Salgado; Fernando Sánchez-Juanes; Francisco J López-Hernández; José M Muñoz-Félix
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

3.  Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice.

Authors:  María González-Núñez; Adela S Riolobos; Orlando Castellano; Isabel Fuentes-Calvo; María de los Ángeles Sevilla; Bárbara Oujo; Miguel Pericacho; Ignacio Cruz-Gonzalez; Fernando Pérez-Barriocanal; Peter ten Dijke; Jose M López-Novoa
Journal:  Dis Model Mech       Date:  2015-09-17       Impact factor: 5.758

4.  L-Endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction.

Authors:  Bárbara Oujo; José M Muñoz-Félix; Miguel Arévalo; Elena Núñez-Gómez; Lucía Pérez-Roque; Miguel Pericacho; María González-Núñez; Carmen Langa; Carlos Martínez-Salgado; Fernando Perez-Barriocanal; Carmelo Bernabeu; José M Lopez-Novoa
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition.

Authors:  Gemma Olmos; José M Muñoz-Félix; Inés Mora; Anton Gerhard Müller; Maria Piedad Ruiz-Torres; José M López-Novoa; Diego Rodríguez-Puyol
Journal:  J Cell Mol Med       Date:  2017-08-30       Impact factor: 5.310

Review 6.  Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review).

Authors:  Xueling Cui; Shumi Shang; Xinran Lv; Jing Zhao; Yan Qi; Zhonghui Liu
Journal:  Mol Med Rep       Date:  2019-04-30       Impact factor: 2.952

7.  Alk1 haploinsufficiency causes glomerular dysfunction and microalbuminuria in diabetic mice.

Authors:  Cindy Lora Gil; Nathalie Henley; François A Leblond; Naoufal Akla; Louis-Philippe Laurin; Virginie Royal; Casimiro Gerarduzzi; Vincent Pichette; Bruno Larrivée
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.